Intrinsiqs

Is Travere Therapeutics, Inc. overvalued?

Travere Therapeutics, Inc. (TVTX) — key valuation metrics and fundamentals.

No verdict
Price
$61.41
Fair value
Current P/E
Normal P/E
Market cap
$5.71B
Dividend yield
0.0%
Return on equity
-55.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares TVTX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.